新型冠狀病毒肺炎疫情下癲癇病房管理策略_Journal of Epilepsy

Authors：

汪銳 ,  馮靈 , 慕潔 , 陳靜 , 何俐 , 周東

四川大學華西醫院神經內科（成都 610041）;

Corresponding?author：

馮靈, Email: fengling216@163.com

Keywords：

DOI：

10.7507/2096-0247.20200052

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 汪銳, 馮靈, 慕潔, 陳靜, 何俐, 周東. 新型冠狀病毒肺炎疫情下癲癇病房管理策略. Journal of Epilepsy, 2020, 6(4): 325-328. doi: 10.7507/2096-0247.20200052 Copy

1.	World Health Organization. Novel Coronavirus (2019-nCoV) situation report –12. (Accessed 2nd Feb2020).
2.	World Health Organization. Coronavirus disease (COVID-2019) situation reports 2020.
3.	Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol, 2020, 10: e201127.
4.	Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis, 2020, 94: 55-58.
5.	Song P, Liu Y, Yu X, et al. Prevalence of epilepsy in China between 1990 and 2015: A systematic review and meta-analysis. J Glob Health, 2017, 7(2): 020706.
6.	Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet, 2012, 380(9848): 1193-1201.
7.	Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia, 2010, 51(5): 883-890.
8.	Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72, 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 2020, 323(13): 1239-1242.
9.	中華人民共和國國家衛生健康委員會. 新型冠狀病毒肺炎診療方案(試行第七版)[EB/OL]. [2020－03－04]. http://www.nhc.gov.cn/yzygj/s7653p/20203/46c9294a7dfe4cef80dc7f5912eb18/files/ce3e6945832a438eaae415350a8ce964.Pdf.
10.	Golyala A, Kwan P. Drug development for refractory epilepsy: The past 25 years and beyond. Seizure, 2017, 44: 147-156.
11.	Qiu W, Chu C, Mao A, et al. The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: A case comparison study. J Environ Public Health, 2018, 2018: 2710185.
12.	賴婉琳, 彭安嬌, 張霖, 等. 2019 新型冠狀病毒肺炎疫情爆發期間癲癇患者的焦慮情緒及原因. 癲癇雜志, 2020, 6(2): 175-178.
13.	馮靈, 魯建英, 王云慧, 等. 標準化管理在視頻腦電圖監測中的應用及效果評價. 華西醫學, 2019, 34(6): 653-658.
14.	高在芬, 王江濤, 韓潔, 等. 腦電圖檢查在新型冠狀病毒感染疫情期間診療及防控建議. 中風與神經疾病雜志, 2020, 37(3): 209-212.
15.	Liu S, Yang L, Zhang C, et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, 7(4): e17-e18.
16.	Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the iInitial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health, 2020, 17(5): 1729.
17.	Munger Clary HM, Snively BM, Hamberger MJ. Anxiety is common and independently associated with clinical features of epilepsy. Epilepsy & behavior, 2018, 85: 64-71.
18.	戴園園. 新型冠狀病毒疫情期間癲癇患者的情緒如何調節. 癲癇雜志, 2020, 6(2): 170-171.

1. World Health Organization. Novel Coronavirus (2019-nCoV) situation report –12. (Accessed 2nd Feb2020).
2. World Health Organization. Coronavirus disease (COVID-2019) situation reports 2020.
3. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol, 2020, 10: e201127.
4. Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis, 2020, 94: 55-58.
5. Song P, Liu Y, Yu X, et al. Prevalence of epilepsy in China between 1990 and 2015: A systematic review and meta-analysis. J Glob Health, 2017, 7(2): 020706.
6. Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet, 2012, 380(9848): 1193-1201.
7. Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia, 2010, 51(5): 883-890.
8. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72, 314 cases from the Chinese Center for Disease Control and Prevention. Jama, 2020, 323(13): 1239-1242.
9. 中華人民共和國國家衛生健康委員會. 新型冠狀病毒肺炎診療方案(試行第七版)[EB/OL]. [2020－03－04]. http://www.nhc.gov.cn/yzygj/s7653p/20203/46c9294a7dfe4cef80dc7f5912eb18/files/ce3e6945832a438eaae415350a8ce964.Pdf.
10. Golyala A, Kwan P. Drug development for refractory epilepsy: The past 25 years and beyond. Seizure, 2017, 44: 147-156.
11. Qiu W, Chu C, Mao A, et al. The impacts on health, society, and economy of SARS and H7N9 outbreaks in China: A case comparison study. J Environ Public Health, 2018, 2018: 2710185.
12. 賴婉琳, 彭安嬌, 張霖, 等. 2019 新型冠狀病毒肺炎疫情爆發期間癲癇患者的焦慮情緒及原因. 癲癇雜志, 2020, 6(2): 175-178.
13. 馮靈, 魯建英, 王云慧, 等. 標準化管理在視頻腦電圖監測中的應用及效果評價. 華西醫學, 2019, 34(6): 653-658.
14. 高在芬, 王江濤, 韓潔, 等. 腦電圖檢查在新型冠狀病毒感染疫情期間診療及防控建議. 中風與神經疾病雜志, 2020, 37(3): 209-212.
15. Liu S, Yang L, Zhang C, et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry, 2020, 7(4): e17-e18.
16. Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the iInitial stage of the 2019 Coronavirus Disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health, 2020, 17(5): 1729.
17. Munger Clary HM, Snively BM, Hamberger MJ. Anxiety is common and independently associated with clinical features of epilepsy. Epilepsy & behavior, 2018, 85: 64-71.
18. 戴園園. 新型冠狀病毒疫情期間癲癇患者的情緒如何調節. 癲癇雜志, 2020, 6(2): 170-171.

Previous Article
Study on the home care experience of parents of children with epilepsy in a hospital in Henan Province
Next Article
癲癇共患孤獨癥譜系障礙的分子遺傳學研究進展

Journal of Epilepsy

新型冠狀病毒肺炎疫情下癲癇病房管理策略

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content